[ad_1]
Jan 25 (Reuters) – Novartis AG:
* NOVARTIS UK BREXIT STATEMENT
* FOLLOWING PARLIAMENT’S VOTE, THE RISK OF UK EXITING THE EU WITHOUT A DEAL IS INCREASED AND THIS WILL BE HUGELY IMPACTFUL FOR PATIENTS
* BUILDING INCREASED INVENTORIES ACROSS OUR PORTFOLIO OF MEDICINES IN THE UK AHEAD OF BREXIT
* IS CONTINUING TO EXECUTE CONTINGENCY PLANS AND MAKE ALL PREPARATIONS POSSIBLE TO ENSURE CONTINUITY OF SUPPLY TO UK PATIENTS Source (bit.ly/2Sa6Iqg) Further company coverage:
Our Standards:The Thomson Reuters Trust Principles.
[ad_2]
Source link Google News